(Q36978448)

17 August 2017

A therapeutic dose of zolpidem has limited abuse-like effects in drug-naïve females: a pilot study (English)

1 reference

17 August 2017

Stephanie C Licata

1

1 reference

17 August 2017

David M Penetar

series ordinal

2

1 reference

17 August 2017

Steven Dunlap

series ordinal

3

1 reference

17 August 2017

Scott E Lukas

series ordinal

4

1 reference

17 August 2017

language of work or name

English

0 references

publication date

22 September 2008

1 reference

European Journal of Pharmacology

17 August 2017

1 reference

17 August 2017

598

1 reference

17 August 2017

1-3

1 reference

17 August 2017

64-67

1 reference

Gender differences in sleep disorders

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

Patient characteristics and patterns of drug use for sleep complaints in the United States: analysis of National Ambulatory Medical Survey data, 1997-2002.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

Zolpidem at supratherapeutic doses can cause drug abuse, dependence and withdrawal seizure.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

Pharmacokinetic properties of zolpidem in elderly and young adults: possible modulation by testosterone in men.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

Principles of initial experimental drug abuse liability assessment in humans

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

Epidemiological evidence for a low abuse potential of zolpidem

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

Benzodiazepine-receptor ligands in humans: acute performance-impairing, subject-rated and observer-rated effects

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

Benzodiazepine self-administration in humans and laboratory animals--implications for problems of long-term use and abuse.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

Zolpidem-induced psychosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

Benzodiazepines: use, abuse, and consequences

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

A critical appraisal of 98.6 degrees F, the upper limit of the normal body temperature, and other legacies of Carl Reinhold August Wunderlich

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

Zolpidem, triazolam, and temazepam: behavioral and subject-rated effects in normal volunteers.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

Drug preference in normal volunteers: effects of age and time of day.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

Zolpidem behavioral pharmacology in baboons: self-injection, discrimination, tolerance and withdrawal

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

Zolpidem abuse, dependence and withdrawal syndrome: sex as susceptibility factor for adverse effects.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

Comparison of zolpidem and midazolam self-administration under progressive-ratio schedules: consumer demand and labor supply analyses

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

Dependence on zolpidem: a report of two cases

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

A postmarketing study of relative abuse liability of hypnotic sedative drugs

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

Zolpidem dependence case series: possible neurobiological mechanisms and clinical management

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

The abuse potential of zolpidem administered alone and with alcohol

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

Reinforcing properties of lorazepam in normal volunteers.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

Lack of preference for flurazepam in normal volunteers.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

Assessing pentobarbital preference in normal volunteers using a cumulative dosing procedure

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2585358

Zolpidem and triazolam interact differentially with a delay interval on a digit-enter-and-recall task

4 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18831970

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prescribed daily doses and 'risk factors' associated with the use of benzodiazepines in primary care

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18831970

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Behavioral and subjective effects of DN-2327 (pazinaclone) and alprazolam in normal volunteers

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18831970

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.EJPHAR.2008.09.011

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

18831970

1 reference